Biogen
Neurology & CNS Therapeutics · Prescription Drugs

Biogen: Risk & public record

Biogen: 28k t CO₂e reported for 2023, 1,653 research papers in five years, $4.2M of EU lobbying in 2025, 38 federal court cases.

Data updated Nov 20, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
Biogen Inc. · dol.gov ↗
Not checked
Postings are real
Alion truth index: B
81/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Domain in use
biogen.com: first seen in registries and web archives · lookup.icann.org ↗
since 1996
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Domain and mail securitybiogen.com · Nov 14, 2026
Spoofed mail (DMARC)
Spoofed mail is rejected · dns.google ↗
Good
Who may send its mail (SPF)
Other senders soft-fail (~all) · dns.google ↗
Good
HTTPS certificate
Valid certificate · Amazon · crt.sh ↗
Good
HTTPS enforced (HSTS)
Not enforced · hstspreload.org ↗
Weak
Security contact (security.txt)
No security.txt · biogen.com ↗
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy · dns.google ↗
Weak
Signed DNS (DNSSEC)
Not signed · dnsviz.net ↗
Weak
Certificate issuers (CAA)
Any authority may issue certificates · dns.google ↗
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.

Public record

Biogen: 28k t CO₂e reported for 2023, 1,653 research papers in five years, $4.2M of EU lobbying in 2025, 38 federal court cases.

Research outputpapers its people wrote, per OpenAlex
1,653papers in five years
465kcitations
Multiple Sclerosis Research Studies
Medicine
1,339 papers
Alzheimer's disease research and treatments
Neuroscience
534 papers
Polyomavirus and related diseases
Medicine
487 papers
Dementia and Cognitive Impairment Research
Medicine
482 papers
Psoriasis: Treatment and Pathogenesis
Immunology and Microbiology
472 papers

Works most with: Harvard University, Mass General Brigham, Massachusetts General Hospital, F. Hoffmann-La Roche AG, Pfizer (United States), University of London

ClimateSBTi targets, US EPA and EU ETS emissions

Its SBTi commitment was removed

28kt CO₂e at US sites, 2023
1site-years reported
BIOGEN INC
US EPA GHGRP · CAMBRIDGE, MA · 2023
28k t
Influence
US lobbying
2025 · Todd Strategy Group $200,000, FEDERAL STREET STRATEGIES, LLC $200,000, DLA Piper LLP · disclosurespreview.house.gov ↗
$4.2M
EU lobbying, declared
2025 · Acumen Public Affairs, FTI Consulting Belgium · transparency-register.europa.eu ↗
EUR 300,000–399,999
Employees' political contributions, 2026 cycle
1,195 contributions · their own money, not the company's; names not shown · fec.gov ↗
$179k
Company PAC, 2026 cycle
to candidates: Democrats $58k · Republicans $66k · fec.gov ↗
87
Patents
Published US applications
4
US federal cases naming it as a party
May 2016 – Jan 2026 · 30 as defendant · 26 closed
Most common: 850 Securities/Commodities 4, 410 Anti-Trust 4, 830 Patent 3, 791 Labor: E.R.I.S.A. 2
38
The case list: courts, dates and the other sidePremiumUnlockor this company alone for 30 days · 50 credits
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.